KLK13

This MedLibrary.org supplementary page on KLK13 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Kallikrein-related peptidase 13
Identifiers
Symbols KLK13; DKFZP586J1923; KLK-L4; KLKL4
External IDs OMIM: 605505 MGI3615275 HomoloGene56714
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 26085 626834
Ensembl ENSG00000167759 ENSMUSG00000054046
Uniprot Q9UKR3 n/a
Refseq NM_015596 (mRNA)
NP_056411 (protein)
XM_001001722 (mRNA)
XP_001001722 (protein)
Location Chr 19: 56.25 - 56.26 Mb Chr 7: 43.58 - 43.77 Mb
Pubmed search [1] [2]

Kallikrein-related peptidase 13, also known as KLK13, is a human gene.[1]

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.[1]

References

Further reading

  • Diamandis EP, Yousef GM, Luo LY, et al. (2001). "The new human kallikrein gene family: implications in carcinogenesis.". Trends Endocrinol. Metab. 11 (2): 54–60. PMID 10675891. 
  • Yousef GM, Chang A, Diamandis EP (2000). "Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues.". J. Biol. Chem. 275 (16): 11891–8. PMID 10766816. 
  • Yousef GM, Chang A, Scorilas A, Diamandis EP (2000). "Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.". Biochem. Biophys. Res. Commun. 276 (1): 125–33. doi:10.1006/bbrc.2000.3448. PMID 11006094. 
  • Gan L, Lee I, Smith R, et al. (2001). "Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region.". Gene 257 (1): 119–30. PMID 11054574. 
  • Chang A, Yousef GM, Jung K, et al. (2002). "Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.". Anticancer Res. 21 (5): 3147–52. PMID 11848466. 
  • Chang A, Yousef GM, Scorilas A, et al. (2002). "Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.". Br. J. Cancer 86 (9): 1457–64. doi:10.1038/sj.bjc.6600283. PMID 11986781. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Petraki CD, Karavana VN, Diamandis EP (2003). "Human kallikrein 13 expression in normal tissues: an immunohistochemical study.". J. Histochem. Cytochem. 51 (4): 493–501. PMID 12642628. 
  • Komatsu N, Takata M, Otsuki N, et al. (2003). "Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.". J. Invest. Dermatol. 121 (3): 542–9. doi:10.1046/j.1523-1747.2003.12363.x. PMID 12925213. 
  • Petraki CD, Gregorakis AK, Papanastasiou PA, et al. (2004). "Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.". Prostate Cancer Prostatic Dis. 6 (3): 223–7. doi:10.1038/sj.pcan.4500674. PMID 12970725. 
  • Kapadia C, Yousef GM, Mellati AA, et al. (2004). "Complex formation between human kallikrein 13 and serum protease inhibitors.". Clin. Chim. Acta 339 (1-2): 157–67. PMID 14687906. 
  • Grimwood J, Gordon LA, Olsen A, et al. (2004). "The DNA sequence and biology of human chromosome 19.". Nature 428 (6982): 529–35. doi:10.1038/nature02399. PMID 15057824. 
  • Kapadia C, Ghosh MC, Grass L, Diamandis EP (2004). "Human kallikrein 13 involvement in extracellular matrix degradation.". Biochem. Biophys. Res. Commun. 323 (3): 1084–90. doi:10.1016/j.bbrc.2004.08.206. PMID 15381110. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • "Proceedings of the 1st International Symposium on Kallikreins, Lausanne, Switzerland, September 1-3 , 2005." (2006). Biol. Chem. 387 (6): 635–824. doi:10.1515/BC.2006.081. PMID 16800723. 
  • Lundwall A, Band V, Blaber M, et al. (2006). "A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.". Biol. Chem. 387 (6): 637–41. doi:10.1515/BC.2006.082. PMID 16800724. 
  • Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP (2006). "Human kallikrein 13 expression in salivary gland tumors.". Int. J. Biol. Markers 21 (2): 106–10. PMID 16847813. 

Wikipedia content modification information:

  • This page was last modified on 9 July 2008, at 20:45.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "KLK13".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.